Literature DB >> 20573293

Lymph node central necrosis on computed tomography as predictor of extracapsular spread in metastatic head and neck squamous cell carcinoma: pilot study.

R A Zoumalan1, A J Kleinberger, L G T Morris, A Ranade, H Yee, M D DeLacure, D Myssiorek.   

Abstract

OBJECTIVE: This study aimed (1) to investigate the relationship between the presence of lymph node central necrosis, viewed on pre-operative computed tomography imaging, and the occurrence of histopathologically determined metastatic lymph node extracapsular spread and (2) to determine whether a larger scale study would be valuable.
MATERIALS AND METHODS: Pre-operative computed tomography scans, surgical records and post-operative histopathological analysis results were reviewed for 19 consecutive neck dissections performed in 17 patients with head and neck squamous cell carcinoma.
RESULTS: A total of 20/26 (77 per cent) lymph nodes with central necrosis had extracapsular spread on histopathological analysis. Twenty of 21 (95 per cent) lymph nodes with extracapsular spread had central necrosis on pre-operative computed tomography. Thirty-four of 40 (85 per cent) lymph nodes without extracapsular spread had no evidence of central necrosis on computed tomography. Only three of 12 (25 per cent) patients with lymph node central necrosis identified on pre-operative computed tomography were found to have actual necrosis on final histopathological analysis.
CONCLUSIONS: Lymph node central necrosis viewed on pre-operative computed tomography scans is a useful indicator of metastatic lymph node extracapsular spread, with a sensitivity of 95 per cent, a specificity of 85 per cent, a positive predictive value of 69 per cent and a negative predictive value of 98 per cent. Lymph node diameter is not a sensitive indicator of extracapsular spread.

Entities:  

Mesh:

Year:  2010        PMID: 20573293      PMCID: PMC3005594          DOI: 10.1017/S0022215110001453

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  19 in total

1.  Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

Authors:  Jay S Cooper; Thomas F Pajak; Arlene A Forastiere; John Jacobs; Bruce H Campbell; Scott B Saxman; Julie A Kish; Harold E Kim; Anthony J Cmelak; Marvin Rotman; Mitchell Machtay; John F Ensley; K S Clifford Chao; Christopher J Schultz; Nancy Lee; Karen K Fu
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

2.  Cervical lymph node metastasis: assessment of radiologic criteria.

Authors:  M W van den Brekel; H V Stel; J A Castelijns; J J Nauta; I van der Waal; J Valk; C J Meyer; G B Snow
Journal:  Radiology       Date:  1990-11       Impact factor: 11.105

3.  Extracapsular spread of squamous cell carcinoma in neck lymph nodes: prognostic factor of laryngeal cancer.

Authors:  H Hirabayashi; K Koshii; K Uno; H Ohgaki; Y Nakasone; T Fujisawa; N Syouno; T Hinohara; K Hirabayashi
Journal:  Laryngoscope       Date:  1991-05       Impact factor: 3.325

Review 4.  Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis.

Authors:  P M Som
Journal:  AJR Am J Roentgenol       Date:  1992-05       Impact factor: 3.959

5.  Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT.

Authors:  D M Yousem; P M Som; D B Hackney; F Schwaibold; R A Hendrix
Journal:  Radiology       Date:  1992-03       Impact factor: 11.105

6.  Radical neck dissections for squamous carcinomas: pathological findings and their clinical implications with particular reference to transcapsular spread.

Authors:  R L Carter; J M Bliss; K C Soo; C J O'Brien
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-06       Impact factor: 7.038

7.  The extracapsular spread of tumors in cervical node metastasis.

Authors:  J T Johnson; E L Barnes; E N Myers; V L Schramm; D Borochovitz; B A Sigler
Journal:  Arch Otolaryngol       Date:  1981-12

8.  Cervical lymph node metastases. Incidence and implications of extracapsular carcinoma.

Authors:  J T Johnson; E N Myers; C D Bedetti; E L Barnes; V L Schramm; P B Thearle
Journal:  Arch Otolaryngol       Date:  1985-08

9.  Extracapsular spread of carcinoma in cervical lymph nodes. Impact upon survival in patients with carcinoma of the supraglottic larynx.

Authors:  N L Snyderman; J T Johnson; V L Schramm; E N Myers; C D Bedetti; P Thearle
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

10.  Prognostic significance of lymphatic spread in head and neck carcinomas: therapeutic implications.

Authors:  C Grandi; M Alloisio; D Moglia; S Podrecca; L Sala; P Salvatori; R Molinari
Journal:  Head Neck Surg       Date:  1985 Nov-Dec
View more
  11 in total

1.  Metastases to the parotid nodes: CT and MR imaging findings.

Authors:  Nobuo Kashiwagi; Takamichi Murakami; Masafumi Toguchi; Katsuyuki Nakanishi; Shojiro Hidaka; Hideyuki Fukui; Masatomo Kimura; Mutsukazu Kitano; Noriyuki Tomiyama
Journal:  Dentomaxillofac Radiol       Date:  2016-10-11       Impact factor: 2.419

2.  The diagnostic performance of CT and MRI for detecting extranodal extension in patients with head and neck squamous cell carcinoma: a systematic review and diagnostic meta-analysis.

Authors:  Sang Ik Park; Jeffrey P Guenette; Chong Hyun Suh; Glenn J Hanna; Sae Rom Chung; Jung Hwan Baek; Jeong Hyun Lee; Young Jun Choi
Journal:  Eur Radiol       Date:  2020-09-19       Impact factor: 5.315

3.  Lymph Node Central Necrosis on the Computed Tomography as the Predictor of the Extra Capsular Spread in Metastatic Head and Neck Squamous Cell Carcinoma.

Authors:  Aditi Sharma; Ashwin Ashok Jaiswal; Girish Umredkar; Ratiram Barle; Neeta Sharma; Praveer Kumar Banerjee; Amrish Kumar Garg; Ravindranath Membally
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-04-10

4.  Sentinel node necrosis is a negative prognostic factor in patients with nasopharyngeal carcinoma: a magnetic resonance imaging study of 252 patients.

Authors:  L Lu; X Wei; Y H Li; W B Li
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

5.  CT differentiation of enlarged mediastinal lymph node due to anthracosis from metastatic lymphadenopathy: a comparative study proven by endobronchial US-guided transbronchial needle aspiration.

Authors:  Johannes Kirchner; Michael Broll; Phillip Müller; Natalia Pomjanski; Stepfan Biesterfeld; Dieter Liermann; Ralph Kickuth
Journal:  Diagn Interv Radiol       Date:  2015 Mar-Apr       Impact factor: 2.630

6.  Highly aggressive human papillomavirus-related oropharyngeal cancer: clinical, radiologic, and pathologic characteristics.

Authors:  Azeem S Kaka; Bhavna Kumar; Pawan Kumar; Paul E Wakely; Claudia M Kirsch; Matthew O Old; Enver Ozer; Amit Agrawal; Ricardo E Carrau; David E Schuller; Farzan Siddiqui; Theodoros N Teknos
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-06-14

7.  Accuracy of Preoperative Imaging in Detecting Nodal Extracapsular Spread in Oral Cavity Squamous Cell Carcinoma.

Authors:  A H Aiken; S Poliashenko; J J Beitler; A Y Chen; K L Baugnon; A S Corey; K R Magliocca; P A Hudgins
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-30       Impact factor: 3.825

8.  Classifying Neck Lymph Nodes of Head and Neck Squamous Cell Carcinoma in MRI Images with Radiomic Features.

Authors:  Tsung-Ying Ho; Chun-Hung Chao; Shy-Chyi Chin; Shu-Hang Ng; Chung-Jan Kang; Ngan-Ming Tsang
Journal:  J Digit Imaging       Date:  2020-06       Impact factor: 4.056

9.  Cervical nodal necrosis is an independent survival predictor in nasopharyngeal carcinoma: an observational cohort study.

Authors:  Yangkun Luo; Jing Ren; Peng Zhou; Yang Gao; Guangquan Yang; Jinyi Lang
Journal:  Onco Targets Ther       Date:  2016-11-01       Impact factor: 4.147

10.  The Value of Cervical Node Features in Predicting Long-Term Survival of Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era.

Authors:  Li Bai; Fei Han; Yun-Ming Tian; Lei Zeng; Yu-Hong Lan; Xia Yuan
Journal:  Cancer Manag Res       Date:  2021-06-21       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.